Almost 30 percent of cancer studies report conflict of interest

May 11, 2009

A new analysis finds that a considerable number of clinical cancer studies published in respected medical journals have financial connections to pharmaceutical companies. Published in the June 15, 2009 issue of CANCER, a peer-reviewed journal of the American Cancer Society, the study indicates that conflicts of interest may cause some researchers to report biased results that are favorable to companies.

Ties between clinical researchers and companies that make medical devices and drugs have become increasingly complex and controversial, particularly as more researchers compete for scarce federal research funds. In addition to using industry money to support their research, some investigators receive consulting fees, own stock and hold positions within companies that profit from selling the very products they are investigating. These conflicts of interest have raised concerns that studies with ties to industry are biased and are not designed to provide a true test of medical therapies. Many medical journals now require researchers to disclose potential conflicts of interest in the articles they submit for publication.

To get sense of the frequency and impact of conflicts of interest in clinical research, Dr. Reshma Jagsi of the University of Michigan and colleagues reviewed cancer studies appearing in eight highly regarded journals in 2006. These journals included the ; JAMA; the Lancet; the ; the ; Lancet Oncology; Clinical Cancer Research; and CANCER.

Of the 1,534 cancer studies identified in these journals, 29 percent had conflicts of interest that were apparent from review of published author declarations and authorship lists (including industry funding, consulting fees to authors, co-authorship by industry employees, etc.), and 17 percent declared industry funding. Conflicts of interest were most often found in articles with primary authors from departments in medical oncology (45 percent), those from North America (33 percent), and those with male first and senior authors (37 percent).

According to the authors, randomized clinical trials that assessed patient survival were more likely to report a survival advantage associated with the intervention when a conflict of interest was present. These trials are the foundation by which drugs, technologies, diagnostic tests, etc. get approved for use in the clinic and therefore shape the way oncologists practice medicine.

The findings also show that studies with industry funding were more likely to focus on treatment than studies without industry funding (62 percent vs. 36 percent). They were less likely than studies not declaring industry funding to focus on epidemiology, prevention, risk factors, screening or diagnostic methods (20 percent vs. 47 percent).

This analysis revealed that conflicts of interest exist in a considerable number of clinical cancer research articles published in important journals. The authors noted that "attempts to disentangle the cancer research effort from industry merit further attention, and journals should embrace both rigorous standards of disclosure and heightened scrutiny when conflicts exist."

More information: "Frequency, nature, effects, and correlates of conflicts of interest in published clinical cancer research." Reshma Jagsi, Nathan Sheets, Aleksandra Jankovic, Amy R. Motomura, Sudha Amarnath, and Peter A. Ubel. CANCER; Published Online: May 11, 2009 (DOI 10.1002/cncr.24306) Print Issue Date: June 15, 2009.

Source: American Cancer Society (news : web)


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - 3.7 /5 (3 votes)

Rank Filter

Move the slider to adjust rank threshold, so that you can hide some of the comments.


Display comments: newest first

  • jcrow - May 11, 2009
    • Rank: 3 / 5 (2)
    This kind of thing applies to news programs also. Lots of bad information out there.
  • austux - May 11, 2009
    • Rank: 1 / 5 (1)
    The _love_ of money is the root of all kinds of evil. QED.
  • lengould100 - May 11, 2009
    • Rank: 1 / 5 (1)
    Just have to go back to the Reagan policies of the 1980's, where suddenly it became important for university researchers to "hook up" with sponsors in order to reduce the "burden" on the taxpayer. Standard and obvious result....

    The _love_ of money is the root of all kinds of evil. QED.
    And the taxpayer's love of their own money is the most stout of those roots.
  • fcnotpdaaj - May 11, 2009
    • Rank: 1 / 5 (1)
    Hummm journalism hooked up with the crazy left, global warmists hooking up the wht crazy environmentalists. Then the claim from scientists/journalists, we are scientists or we are journalists we wouldnt be biased we have your best interest at heart.

    But isnt it interesting that ACORN, Planned Parenthood, Environmentalists, get their money and couldnt function without governement and the media, support democrats, while the biased media (aka mainstream media) which is the propaganda arm of liberal and democratic parties idology support the current government, support the crazy leftist agenda, and support global warming. As http://www.democr...joke.com keeps pointing out, follow the idology.....

May 11, 2009 all stories

Comments: 4

3.7 /5 (3 votes)
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories




  • hide
  • Relevant PhysicsForums posts

  • Improving the brain through chemistry
    created Nov 07, 2009
  • Sleep / REM Sleep and homeostasis
    created Nov 07, 2009
  • The Biceps Reflex
    created Nov 05, 2009
  • Consequenses of striking a Vein and an artery?
    created Nov 05, 2009
  • More from Physics Forums - Medical Sciences

Other News

Deepening the search  for clues to rheumatoid arthritis

Deepening the search for clues to rheumatoid arthritis

Medicine & Health / Genetics

created 31 minutes ago | popularity not rated yet | comments 0

(PhysOrg.com) -- The gnawing pain of rheumatoid arthritis is a signal that the body’s immune system has hit the wrong target: its own cartilage and bone.


Of Mutants and Mechanisms: Researching Growth-Regulation Proteins That Underlie Cancer

Of Mutants and Mechanisms: Researching Growth-Regulation Proteins That Underlie Cancer

Medicine & Health / Cancer

created 29 minutes ago | popularity not rated yet | comments 0

(PhysOrg.com) --A University of Arkansas researcher will study potential cancer-causing mutants of a protein involved in cell growth regulation, thanks to a supplemental grant from the National Institutes ...


Breast density associated with increased risk of cancer recurrence

Medicine & Health / Cancer

created 3 hours ago | popularity not rated yet | comments 0

A new study finds that women treated for breast cancer are at higher risk of cancer recurrence if they have dense breasts. Published in the December 15, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer ...


Scientists uncover new key to the puzzle of hormone therapy and breast cancer

Scientists uncover new key to the puzzle of hormone therapy and breast cancer

Medicine & Health / Cancer

created 4 hours ago | popularity 5 / 5 (1) | comments 0

The use of postmenopausal hormone therapy has decreased over time in the United States, which researchers suggest may play a key role in the declining rate of atypical ductal hyperplasia, a known risk factor ...


Young tennis players who play only 1 sport are more prone to injuries

Young tennis players who play only one sport are more prone to injuries

Medicine & Health / Health

created 4 hours ago | popularity not rated yet | comments 0

Gifted young athletes are under increasing pressure to play only one sport year round.